UNSPSC 51432304: Imidaprilat

This classification denotes an ace inhibitor with the molecular formula C18H23N3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WUU07Y30IA, chemically known as 4-imidazolidinecarboxylic acid, 3-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1-methyl-2-oxo-, (4s)- but generally known as imidaprilat, which bears US NIH Compound Identifier 5464344. European Medicines Agency schedules Imidaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08144MIG.

UNSPSC 51432304 Imidaprilat is a Commodity code covering pharmaceutical supplies used in emergency medical response and acute care settings. State and local governments buy advanced life support medications under this code for fire rescue departments, emergency medical services (EMS), and hospital systems. The medications procured include vasopressors, antiarrhythmics, and other critical-care injectables required for prehospital and in-hospital emergency protocols. Issuing bodies include municipal fire and EMS departments, county health systems, and city purchasing offices acting on behalf of emergency response agencies. Vendors must meet stringent pharmaceutical supply-chain requirements: products must carry minimum expiration dates of nine months from acceptance, deliver within ten calendar days of order, carry full-year warranties against defects, and manage expired-inventory logistics including pickup and replacement before expiration. Safety Data Sheets compliant with OSHA standards and accessibility documentation meeting WCAG 2.2 Level AA and Section 508 requirements are standard deliverables.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to support Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and an estimated contract value of $40,000. The solicitation called for 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with firm pricing including freight to Tampa and applicable taxes. The contract term runs one year from award with two optional one-year renewals and up to three additional 30-day unilateral extensions. Tampa applied a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount (capped at $10,000) and required SLBE participation documentation including the DMI-20 and DMI-40 forms within ten workdays of intent-to-award notice. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening.